These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
336 related items for PubMed ID: 2284101
1. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification. Cohn SL, Salwen H, Quasney MW, Ikegaki N, Cowan JM, Herst CV, Kennett RH, Rosen ST, DiGiuseppe JA, Brodeur GM. Oncogene; 1990 Dec; 5(12):1821-7. PubMed ID: 2284101 [Abstract] [Full Text] [Related]
2. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study. Cohn SL, Look AT, Joshi VV, Holbrook T, Salwen H, Chagnovich D, Chesler L, Rowe ST, Valentine MB, Komuro H. Cancer Res; 1995 Feb 15; 55(4):721-6. PubMed ID: 7850780 [Abstract] [Full Text] [Related]
3. N-myc amplification and cell proliferation rate in human neuroblastoma. Pession A, Trerè D, Perri P, Rondelli R, Montanaro L, Mantovani W, Derenzini M, Paolucci G. J Pathol; 1997 Nov 15; 183(3):339-44. PubMed ID: 9422991 [Abstract] [Full Text] [Related]
4. In vitro modulation and relationship between N-myc and HLA class I RNA steady-state levels in human neuroblastoma cells. Gross N, Beck D, Favre S. Cancer Res; 1990 Dec 01; 50(23):7532-6. PubMed ID: 1701347 [Abstract] [Full Text] [Related]
5. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. Castle VP, Heidelberger KP, Bromberg J, Ou X, Dole M, Nuñez G. Am J Pathol; 1993 Dec 01; 143(6):1543-50. PubMed ID: 8256847 [Abstract] [Full Text] [Related]
6. N-myc regulation of type I insulin-like growth factor receptor in a human neuroblastoma cell line. Chambéry D, Mohseni-Zadeh S, de Gallé B, Babajko S. Cancer Res; 1999 Jun 15; 59(12):2898-902. PubMed ID: 10383152 [Abstract] [Full Text] [Related]
7. Loss of one HuD allele on chromosome #1p selects for amplification of the N-myc proto-oncogene in human neuroblastoma cells. Grandinetti KB, Spengler BA, Biedler JL, Ross RA. Oncogene; 2006 Feb 02; 25(5):706-12. PubMed ID: 16278682 [Abstract] [Full Text] [Related]
8. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation. Raschella G, Romeo A, Negroni A, Pucci S, Dominici C, Castello MA, Bevilacqua P, Felsani A, Calabretta B. Cancer Res; 1994 Apr 15; 54(8):2251-5. PubMed ID: 8174135 [Abstract] [Full Text] [Related]
9. Integrin expression in human neuroblastoma cells with or without N-myc amplification and in ectopic/orthotopic nude mouse tumors. Flickinger KS, Judware R, Lechner R, Carter WG, Culp LA. Exp Cell Res; 1994 Jul 15; 213(1):156-63. PubMed ID: 8020586 [Abstract] [Full Text] [Related]
10. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification. Cheng NC, Van Roy N, Chan A, Beitsma M, Westerveld A, Speleman F, Versteeg R. Oncogene; 1995 Jan 19; 10(2):291-7. PubMed ID: 7838528 [Abstract] [Full Text] [Related]
11. [Oncogene amplification in human neuroblastomas]. Kanda N, Tsuchida Y, Hayashi Y, Ise T, Takayama J, Utakoji T. Gan To Kagaku Ryoho; 1986 Mar 19; 13(3 Pt 2):661-6. PubMed ID: 3963837 [Abstract] [Full Text] [Related]
12. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines. Sivak LE, Tai KF, Smith RS, Dillon PA, Brodeur GM, Carroll WL. Oncogene; 1997 Oct 16; 15(16):1937-46. PubMed ID: 9365240 [Abstract] [Full Text] [Related]
13. Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line. Foley J, Cohn SL, Salwen HR, Chagnovich D, Cowan J, Mason KL, Parysek LM. Cancer Res; 1991 Dec 01; 51(23 Pt 1):6338-45. PubMed ID: 1933896 [Abstract] [Full Text] [Related]
14. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Yanagihara K, Seyama T, Tsumuraya M, Kamada N, Yokoro K. Cancer Res; 1991 Jan 01; 51(1):381-6. PubMed ID: 1846312 [Abstract] [Full Text] [Related]
15. Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells. Corvi R, Savelyeva L, Schwab M. Cancer Res; 1995 Aug 15; 55(16):3471-4. PubMed ID: 7627947 [Abstract] [Full Text] [Related]
16. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells. Spengler BA, Lazarova DL, Ross RA, Biedler JL. Oncol Res; 1997 Aug 15; 9(9):467-76. PubMed ID: 9495452 [Abstract] [Full Text] [Related]
17. [Oncogen N-myc expression and measurement of DNA ploidy in neuroblastoma: a double staining flow cytometric analysis]. Chassevent A, Bénard J. Bull Cancer; 1997 Mar 15; 84(3):29-34. PubMed ID: 9207866 [Abstract] [Full Text] [Related]
18. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein. Krajewski S, Chatten J, Hanada M, Reed JC. Lab Invest; 1995 Jan 15; 72(1):42-54. PubMed ID: 7837790 [Abstract] [Full Text] [Related]
19. S-cells from a highly N-myc-amplified neuroblastoma are tumorigenic in nude mice. Sleight BJ, Soukup S, Ballard ET, Parysek LM. Anticancer Res; 1993 Jan 15; 13(6A):2031-6. PubMed ID: 8297111 [Abstract] [Full Text] [Related]
20. Chromosome findings in human neuroblastomas xenografted in nude mice. Kaneko Y, Tsuchida Y, Maseki N, Takasaki N, Sakurai M, Saito S. Jpn J Cancer Res; 1985 May 15; 76(5):359-64. PubMed ID: 3924709 [Abstract] [Full Text] [Related] Page: [Next] [New Search]